NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 918,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "f2e0bd23-0c64-44e3-aec2-2f7e85d0697e",
"title": "Stratus Properties Inc (STRS) Reports Significant Shifts in 2023 Financial Results",
"description": "Net Loss: Stratus Properties Inc (STRS) reported a net loss attributable to common stockholders of $(14.8) million, or $(1.85) per diluted share for the year e",
"keywords": "GuruFocus, Article, News, GuruFocus Research, STRS",
"snippet": "Stratus Properties Inc (STRS, Financial), a diversified real estate company with operations primarily in the Austin, Texas area, released its 8-K filing on Marc...",
"url": "https://www.gurufocus.com/news/2399203/stratus-properties-inc-strs-reports-significant-shifts-in-2023-financial-results",
"image_url": "https://static.gurufocus.com/logos/0C00000CEY.png?5",
"language": "en",
"published_at": "2024-03-28T14:11:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "STRS",
"name": "Stratus Properties Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 143.39339,
"sentiment_score": 0.250214,
"highlights": [
{
"highlight": "<em>Stratus</em> <em>Properties</em> <em>Inc</em> (STRS, Financial), a diversified real estate company with operations primarily in the Austin, Texas area, released its 8-K filing on March 28, 2024, revealing a challenging fiscal year that resulted in a net loss.",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Stratus</em> <em>Properties</em> <em>Inc</em> operates through two segments: Real Estate Operations and Leasing Operations, focusing on the development, management, and sale of commercial and residential real estate properties.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Strategic Highlights and Financial Achievements\n\n<em>Stratus</em> <em>Properties</em> Inc's financial achievements in 2023 included the completion of a share repurchase program and the successful construction and lease-up of The Saint June project.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "Balance Sheet and Cash Flow Analysis\n\n<em>Stratus</em> <em>Properties</em> Inc's balance sheet reflects a solid equity base, with total assets of $517.766 million and total liabilities of $223.161 million as of December 31, 2023.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "In conclusion, <em>Stratus</em> <em>Properties</em> <em>Inc</em> faced a challenging 2023, marked by a net loss and decreased revenue from real estate operations. However, the company's increased equity, strategic asset management, and strong liquidity position it well for potential recovery as market conditions improve.",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Stratus</em> <em>Properties</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Stratus</em> <em>Properties</em> <em>Inc</em> (STRS) Reports Significant Shifts in 2023 Financial Results",
"sentiment": 0.2023,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "46a00999-4e53-4664-8f5c-8d96c95ea524",
"title": "China Automotive Systems Inc (CAAS) Reports Record Annual Revenue and Significant Increase in Diluted Net Income Per Share",
"description": "Annual Revenue: Record high at $576.4 million, an 8.8% increase from the previous year.Gross Profit: Rose by 24.5% to $103.8 million with gross margin improvin",
"keywords": "GuruFocus, Article, News, GuruFocus Research, CAAS",
"snippet": "China Automotive Systems Inc (CAAS, Financial), a leading power steering components and systems supplier in China, released its 8-K filing on March 28, 2024, di...",
"url": "https://www.gurufocus.com/news/2399138/china-automotive-systems-inc-caas-reports-record-annual-revenue-and-significant-increase-in-diluted-net-income-per-share",
"image_url": "https://static.gurufocus.com/logos/0C000007BP.png?5",
"language": "en",
"published_at": "2024-03-28T13:31:55.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CAAS",
"name": "China Automotive Systems, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 121.42889,
"sentiment_score": 0.2898,
"highlights": [
{
"highlight": "<em>China</em> <em>Automotive</em> <em>Systems</em> <em>Inc</em> (CAAS, Financial), a leading power steering components and systems supplier in China, released its 8-K filing on March 28, 2024, disclosing unaudited financial results for the fourth quarter and audited results for the fiscal year ended December 31, 2023.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>China</em> <em>Automotive</em> <em>Systems</em> <em>Inc</em> (CAAS, Financial) remains a key player in the automotive industry, with a broad range of power steering products and a strong customer base that includes major auto manufacturers in China and North America.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>China</em> <em>Automotive</em> <em>Systems</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>China</em> <em>Automotive</em> <em>Systems</em> <em>Inc</em> (CAAS) Reports Record Annual Revenue and Significant Increase in Diluted Net Income Per Share",
"sentiment": 0.6486,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "752eb7bc-883c-4507-877c-dc189aacbc27",
"title": "Kodiak Sciences Inc (KOD) Posts Q4 and Full Year 2023 Financial Results",
"description": "Net Loss: Reported a net loss of $59.5 million for Q4 2023, equating to $1.13 per share, aligning with analyst EPS estimates of -$0.89.Research and Development",
"keywords": "GuruFocus, Article, News, GuruFocus Research, KOD",
"snippet": "Kodiak Sciences Inc (KOD, Financial) released its 8-K filing on March 28, 2024, detailing its fourth quarter and full year financial results for 2023, along wit...",
"url": "https://www.gurufocus.com/news/2399078/kodiak-sciences-inc-kod-posts-q4-and-full-year-2023-financial-results",
"image_url": "https://static.gurufocus.com/logos/0C000092TG.png?5",
"language": "en",
"published_at": "2024-03-28T12:32:54.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "KOD",
"name": "Kodiak Sciences Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 140.54245,
"sentiment_score": 0.22295,
"highlights": [
{
"highlight": "<em>Kodiak</em> <em>Sciences</em> <em>Inc</em> (KOD, Financial) released its 8-K filing on March 28, 2024, detailing its fourth quarter and full year financial results for 2023, along with recent business highlights.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kodiak</em> <em>Sciences</em>' flagship product candidate, KSI-301, is a novel antibody biopolymer conjugate, currently in clinical trials for treatment-naive subjects with neovascular wet AMD.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Victor Perlroth, CEO of <em>Kodiak</em> <em>Sciences</em>, expressed confidence in the company's portfolio of late-stage clinical assets and their potential to address unmet needs in retinal vascular diseases.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "This financial stability is crucial for <em>Kodiak</em> <em>Sciences</em> as it continues to invest in the development of its clinical programs and prepares for potential commercialization.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kodiak</em> <em>Sciences</em>' commitment to advancing its clinical programs is evident in the progression of tarcocimab, its most advanced program, with multiple pivotal studies demonstrating its durability and safety.",
"sentiment": 0.7693,
"highlighted_in": "main_text"
},
{
"highlight": "In conclusion, <em>Kodiak</em> <em>Sciences</em> <em>Inc</em> (KOD, Financial) has demonstrated a disciplined approach to managing its R&D and G&A expenses while advancing its clinical programs.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Kodiak</em> <em>Sciences</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kodiak</em> <em>Sciences</em> <em>Inc</em> (KOD) Posts Q4 and Full Year 2023 Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "KOD.MX",
"name": "Kodiak Sciences Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 140.52649,
"sentiment_score": 0.22295,
"highlights": [
{
"highlight": "<em>Kodiak</em> <em>Sciences</em> <em>Inc</em> (KOD, Financial) released its 8-K filing on March 28, 2024, detailing its fourth quarter and full year financial results for 2023, along with recent business highlights.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kodiak</em> <em>Sciences</em>' flagship product candidate, KSI-301, is a novel antibody biopolymer conjugate, currently in clinical trials for treatment-naive subjects with neovascular wet AMD.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Victor Perlroth, CEO of <em>Kodiak</em> <em>Sciences</em>, expressed confidence in the company's portfolio of late-stage clinical assets and their potential to address unmet needs in retinal vascular diseases.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "This financial stability is crucial for <em>Kodiak</em> <em>Sciences</em> as it continues to invest in the development of its clinical programs and prepares for potential commercialization.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kodiak</em> <em>Sciences</em>' commitment to advancing its clinical programs is evident in the progression of tarcocimab, its most advanced program, with multiple pivotal studies demonstrating its durability and safety.",
"sentiment": 0.7693,
"highlighted_in": "main_text"
},
{
"highlight": "In conclusion, <em>Kodiak</em> <em>Sciences</em> <em>Inc</em> (KOD, Financial) has demonstrated a disciplined approach to managing its R&D and G&A expenses while advancing its clinical programs.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Kodiak</em> <em>Sciences</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kodiak</em> <em>Sciences</em> <em>Inc</em> (KOD) Posts Q4 and Full Year 2023 Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "74e0fd91-342e-422a-a548-c0c8f23e997c",
"title": "Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update",
"description": "Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 ...",
"keywords": "OTC Markets:AGRX, Agile Therapeutics, Inc.",
"snippet": "Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33%\n\n\n\nTwirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022\n\nCo...",
"url": "https://www.globenewswire.com/news-release/2024/03/28/2853966/30925/en/Agile-Therapeutics-Reports-Fourth-Quarter-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/99279611-bca9-42ad-84ee-0ffa6e90c2fb",
"language": "en",
"published_at": "2024-03-28T12:05:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "AGRX",
"name": "Agile Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 69.569,
"sentiment_score": 0.20981,
"highlights": [
{
"highlight": "., March 28, 2024 (GLOBE NEWSWIRE) -- <em>Agile</em> <em>Therapeutics</em>, <em>Inc</em>. (Pink: AGRX), a women's healthcare company, today reported financial results for the three and twelve months ended December 31, 2023 and provided a corporate update.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "“2023 was a year for Agile that we believe demonstrated our ability to continue to grow Twirla,” said <em>Agile</em> <em>Therapeutics</em> Chairperson and Chief Executive Officer Al Altomari.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "ET\n\n\n\nWebcast (live and archived)\n\n\n\nEvents & Presentations\n\n\n\nRegistration Link\n\n\n\nRegister Here\n\n\n\n\n\n\n\nA live webcast of the conference call may be accessed via the Investor Relations portion of the <em>Agile</em> <em>Therapeutics</em> website at https://ir.agiletherapeutics.com/events-and-presentations.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Agile</em> <em>Therapeutics</em>, <em>Inc</em>.\n\n<em>Agile</em> <em>Therapeutics</em> is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.",
"sentiment": 0.7971,
"highlighted_in": "main_text"
},
{
"highlight": "Contact:\n\[email protected]\n\n\n\n\n\n<em>Agile</em> <em>Therapeutics</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "par value, 300,000,000 shares authorized, 2,963,657 and 859,402 issued and outstanding at December 31, 2023 and December 31, 2022, respectively 4 4 Additional paid-in capital 406,846 403,153 Accumulated deficit (423,168 ) (408,702 ) Total stockholders’ deficit (16,318 ) (5,545 ) Total liabilities and stockholders’ deficit $ 10,255 $ 14,242\n\n\n\n\n\n\n\n<em>Agile</em>",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Therapeutics</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(0.10 ) $ (6.71 ) $ (1.18 ) Weighted-average common shares (basic and diluted) 2,963,657 41,232,562 2,156,726 21,610,947 Comprehensive loss: Net loss $ (4,467 ) $ (3,929 ) $ (14,465 ) $ (25,412 ) Other comprehensive income: Unrealized (loss) gain on marketable securities - - - - Comprehensive loss $ (4,467 ) $ (3,929 ) $ (14,465 ) $ (25,412 )\n\n\n\n\n\n<em>Agile</em>",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Therapeutics</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Agile</em> <em>Therapeutics</em> Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "b873e0df-c09c-4d65-a79e-9f28ac433302",
"title": "Jiayin Group Inc. Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results",
"description": "-- Full Year Revenue Grew 67.1% to RMB5,467 million -- -- Full Year Net Income Grew 9.9% to RMB1,298 million -- SHANGHAI, China, March 28, 2024 ...",
"keywords": "Nasdaq:JFIN, Jiayin Group Inc.",
"snippet": "-- Full Year Revenue Grew 67.1% to RMB5,467 million --\n\n-- Full Year Net Income Grew 9.9% to RMB1,298 million --\n\nSHANGHAI, China, March 28, 2024 (GLOBE NEWSWIR...",
"url": "https://www.globenewswire.com/news-release/2024/03/28/2853900/0/en/Jiayin-Group-Inc-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Unaudited-Financial-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/db4fdea5-d9f0-4183-a154-201f1e2677d2",
"language": "en",
"published_at": "2024-03-28T11:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "JFIN",
"name": "Jiayin Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 117.39853,
"sentiment_score": 0.247791,
"highlights": [
{
"highlight": "-- Full Year Revenue Grew 67.1% to RMB5,467 million --\n\n-- Full Year Net Income Grew 9.9% to RMB1,298 million --\n\nSHANGHAI, China, March 28, 2024 (GLOBE NEWSWIRE) -- <em>Jiayin</em> <em>Group</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(“<em>Jiayin</em>” or the “Company”) (<em>NASDAQ</em>: <em>JFIN</em>), a leading fintech platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Jiayin</em> <em>Group</em> <em>Inc</em>.\n\n<em>Jiayin</em> <em>Group</em> <em>Inc</em>. is a leading fintech platform in China committed to facilitating effective, transparent, secure and fast connections between underserved individual borrowers and financial institutions. The origin of the business of the Company can be traced back to 2011.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "For investor and media inquiries, please contact:\n\n<em>Jiayin</em> Group\n\nMr. Shawn Zhang\n\nEmail: [email protected]\n\n<em>JIAYIN</em> <em>GROUP</em> <em>INC</em>.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "568,819 80,116 Accrued expenses and other current liabilities 572,701 731,863 103,081 Other payable related to the disposal of Shanghai Caiyin 188,300 - - Lease liabilities 27,465 47,958 6,755 TOTAL LIABILITIES 1,779,367 3,264,305 459,768 TOTAL SHAREHOLDERS' EQUITY 1,241,503 2,380,461 335,281 TOTAL LIABILITIES AND EQUITY 3,020,870 5,644,766 795,049\n\n\n\n\n\n<em>JIAYIN</em>",
"sentiment": -0.7695,
"highlighted_in": "main_text"
},
{
"highlight": "<em>GROUP</em> <em>INC</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "benefit (expense) 49,994 (62,561 ) (8,812 ) (155,398 ) (247,616 ) (34,876 ) Share of gain (loss) from equity method\n\ninvestments (109 ) 2,012 283 7,940 (1,990 ) (280 ) Net income 533,698 367,634 51,780 1,180,232 1,297,576 182,760 Less: net income (loss) attributable to\n\nnoncontrolling interest 761 (128 ) (18 ) 574 (43 ) (6 ) Net income attributable to\n\n<em>Jiayin</em>",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Group</em> <em>Inc</em>. 532,937 367,762 51,798 1,179,658 1,297,619 182,766 Weighted average shares used in\n\ncalculating net income per share: - Basic and diluted 213,789,483 213,462,066 213,462,066 215,259,640 213,996,233 213,996,233 Net income per share: - Basic and diluted 2.49 1.72 0.24 5.48 6.06 0.85 Net income per ADS: - Basic and diluted 9.97 6.88 0.96 21.92",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "comprehensive income,\n\nnet of tax of nil: Foreign currency translation\n\nadjustments (4,181 ) (15,146 ) (2,133 ) 14,802 (7,132 ) (1,005 ) Comprehensive income 529,517 352,488 49,647 1,195,034 1,290,444 181,755 Comprehensive Income (loss)\n\nattributable to noncontrolling interest 875 (94 ) (13 ) 534 (98 ) (14 ) Total comprehensive income\n\nattributable to <em>Jiayin</em>",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Group</em> <em>Inc</em>. 528,642 352,582 49,660 1,194,500 1,290,542 181,769\n\n______________________\n\n1 “Loan facilitation volume” refers the loan volume facilitated in Mainland China during the period presented.\n\n2 “Repeat borrowing rate” refers to the repeat borrowers as a percentage of all of our borrowers in Mainland China.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Jiayin</em> <em>Group</em> <em>Inc</em>. Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "9d65ef28-dfa7-40aa-bd32-3f1dc4435e68",
"title": "Zscaler Is Attractively Valued Amid Growing Digital Reliance",
"description": "Zscaler Inc. (ZS) has one of the highest growth rates in its industry, based on my analysis of dominant peers. As such, I consider it a significant investment i",
"keywords": "GuruFocus, Article, News, Oliver Rodzianko, ZS, PANW, CSCO, FTNT, AMZN, MSFT, SAP, ZM, GOOGL, CRM, NOW, WORK, AAPL",
"snippet": "Zscaler Inc. (ZS, Financial) has one of the highest growth rates in its industry, based on my analysis of dominant peers. As such, I consider it a significant i...",
"url": "https://www.gurufocus.com/news/2396064/zscaler-is-attractively-valued-amid-growing-digital-reliance",
"image_url": "https://static.gurufocus.com/logos/0C0000BEGL.png?12",
"language": "en",
"published_at": "2024-03-28T14:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CSCO",
"name": "Cisco Systems, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 14.874008,
"sentiment_score": 0.8074,
"highlights": [
{
"highlight": "<em>Cisco</em> <em>Systems</em> <em>Inc</em>. (CSCO, Financial): The most well-financed peer, the company has an extensive range of security products, such as firewalls, VPNs and advanced malware protection.\n\nFortinet Inc. (FTNT, Financial): The company covers everything from firewalls to secure SD-WAN, which manages traffic across wide area networks for higher efficiency.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "FTNT",
"name": "Fortinet, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 19.494343,
"sentiment_score": 0.56266,
"highlights": [
{
"highlight": "<em>Fortinet</em> <em>Inc</em>. (FTNT, Financial): The company covers everything from firewalls to secure SD-WAN, which manages traffic across wide area networks for higher efficiency.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "It is useful for us to put these four peers into proper perspective based on some of the core financial metrics:\n\nZscaler Palo Alto Networks Cisco <em>Fortinet</em> IPO 2018 2012 1990 2009 Market Cap $29.22 B $92.71 B $201.53 B $52.1 B Equity-to-Asset 0.24 0.24 0.46 -0.06 Net Margin -7.32% 30.24% 23.49% 21.64% 3Y Rev Growth Rate 49.6% 19.8% 6.2% 29.6% FWD PE",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Ratio 82 56 13.4 40\n\nIt is quite evident to me that Zscaler has particular appeal compared to some of the newer players, namely Palo Alto Networks and <em>Fortinet</em>, as it shows higher growth.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "In short, Zscaler offers a one-point solution with some of the most advanced technology on the market, which I think outperforms Palo Alto Networks, Cisco and <em>Fortinet</em> operationally in many areas, specifically as it relates to cloud security and simplicity in these operations.",
"sentiment": 0.7152,
"highlighted_in": "main_text"
},
{
"highlight": "First of all, consider each of the four peers compared based on the two valuation metrics:\n\nZscaler Palo Alto Networks Cisco <em>Fortinet</em> P/FCF 57 34.5 15 31 P/OCF 44 33 14 28\n\nZscaler is quite clearly the highest valued of the four, but investors should consider that its valuation has come down considerably in the last few years.",
"sentiment": 0.4464,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ZS",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 44.126812,
"sentiment_score": 0.4881,
"highlights": [
{
"highlight": "<em>Zscaler</em> <em>Inc</em>. (ZS, Financial) has one of the highest growth rates in its industry, based on my analysis of dominant peers. As such, I consider it a significant investment in artificieal intelligecne-integrated cybersecurity, with a particular moat in how it protects cloud operations.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Ratio 82 56 13.4 40\n\nIt is quite evident to me that <em>Zscaler</em> has particular appeal compared to some of the newer players, namely Palo Alto Networks and Fortinet, as it shows higher growth.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Among these are:\n\n<em>Zscaler</em> Internet Access: Efficient in secure internet and SaaS application access, replacing traditional VPN and firewall technology.\n\n<em>Zscaler</em> Private Access: Access to private applications securely, without a VPN, without bringing users onto the internet.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> Cloud Protection: Provides security for public cloud environments.\n\n<em>Zscaler</em> Digital Experience: A comprehensive monitoring solution that ensures optimal user experience of <em>Zscaler</em> tools while also optimizing security.",
"sentiment": 0.9118,
"highlighted_in": "main_text"
},
{
"highlight": "My own opinion is that the market as it relates to <em>Zscaler</em> will grow faster than this, even more so than Mordor's estimate of an 11.44% CAGR for the cybersecurity market from 2024 to 2029.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "That being said, one constant seems to ring true, which is that most, if not all, of these labor demands will be significantly dependent on digital workflows and associated data protection and security, which will be highly beneficial for companies like <em>Zscaler</em>.",
"sentiment": 0.8709,
"highlighted_in": "main_text"
},
{
"highlight": "First of all, consider each of the four peers compared based on the two valuation metrics:\n\n<em>Zscaler</em> Palo Alto Networks Cisco Fortinet P/FCF 57 34.5 15 31 P/OCF 44 33 14 28\n\n<em>Zscaler</em> is quite clearly the highest valued of the four, but investors should consider that its valuation has come down considerably in the last few years.",
"sentiment": 0.4464,
"highlighted_in": "main_text"
},
{
"highlight": "Risks\n\nThere is evidently a risk that <em>Zscaler</em> will be outcompeted by other cybersecurity companies that develop, and it appears that there is not a concentrated monopoly in cybersecurity at this time.",
"sentiment": -0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> investors should watch the market carefully, as there may come a time in the not-too-distant future when it makes sense to sell the stake for another provider if it becomes clear the balance of power has begun to shift.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "What is now cutting-edge, the cloud, could in the future become outdated and <em>Zscaler</em> has an enormous task at hand in keeping up to date with the rapid shifts that are likely to happen in the AI and associated cybersecurity industries.",
"sentiment": 0.5413,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> Is Attractively Valued Amid Growing Digital Reliance",
"sentiment": 0.7783,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "1192e261-b906-45cf-becc-4620fe418209",
"title": "Apple: A Compounding Machine Slowing Down",
"description": "Apple Inc. (AAPL) is on the podium for being among the most well-known, highest-market capitalized and profitable companies in the world. It generally needs no",
"keywords": "GuruFocus, Article, News, Pietro Lavisci, MD, AAPL, XKRX:005930, SPOT",
"snippet": "Apple Inc. (AAPL, Financial) is on the podium for being among the most well-known, highest-market capitalized and profitable companies in the world. It generall...",
"url": "https://www.gurufocus.com/news/2388474/apple-a-compounding-machine-slowing-down",
"image_url": "https://static.gurufocus.com/photos/companies/Apple_3rdst_promenade_SantaMonica.jpg",
"language": "en",
"published_at": "2024-03-28T14:00:01.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 26.351423,
"sentiment_score": 0.303236,
"highlights": [
{
"highlight": "<em>Apple</em> <em>Inc</em>. (AAPL, Financial) is on the podium for being among the most well-known, highest-market capitalized and profitable companies in the world. It generally needs no introduction, but as it says in its 10-K filing:\n\n\"<em>Apple</em> revolutionized personal technology with the introduction of the Macintosh in 1984.",
"sentiment": 0.09,
"highlighted_in": "main_text"
},
{
"highlight": "Today, <em>Apple</em> leads the world in innovation with iPhone, iPad, Mac, <em>Apple</em> Watch, and <em>Apple</em> TV. Apple's five software platforms — iOS, iPadOS, macOS, watchOS, and tvOS — provide seamless experiences across all <em>Apple</em> devices and empower people with breakthrough services including the App Store, <em>Apple</em> Music, <em>Apple</em> Pay, and iCloud.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> further divides its business into five categories. The iPhone has the lion share of it all with 52.20% of net sales, followed by Services (22.20%) and then the other hardware/products, Wearable, Home and Accessories (10.40%), Mac (7.60%) and iPad (7.40%).\n\nWhat does <em>Apple</em> mean by services, exactly?",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": ".), subscription-based services (including <em>Apple</em> Arcade for games, <em>Apple</em> Fitness+SM for personalized fitness, <em>Apple</em> Music, <em>Apple</em> News+ and <em>Apple</em> TV+ with exclusive original content and live sports ever expanding).",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Last but not least are Payment Services (including <em>Apple</em> Card, a co-branded credit card not yet available in Italy, and <em>Apple</em> Pay, a cashless payment service based on NFC technology).\n\nThe newest of these services is <em>Apple</em> Sports, which was launched in February.",
"sentiment": -0.5573,
"highlighted_in": "main_text"
},
{
"highlight": "Risks\n\nAs is always the case with tech companies, <em>Apple</em> is facing several risks in both the short term and long term.",
"sentiment": -0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> has definitely maintained a solid balance sheet since its founding, but lately this trend has been inverting.\n\nSince 2019, some common financial strength ratios have decreased, in particular due to declining cash and equivalents and short-term investments, to the tune of $39 billion over a five-year period.",
"sentiment": 0.7543,
"highlighted_in": "main_text"
},
{
"highlight": "On the flip side, <em>Apple</em> managed to post sound business performance with a 59% increase in cash from operations and an even more impressive 68% surge in free cash flow over the same period from 2019 to 2023.",
"sentiment": 0.8467,
"highlighted_in": "main_text"
},
{
"highlight": "There is no one scenario in which <em>Apple</em> can comfortably be viewed as on sale or a possible buy.\n\nAssuming the 15.80 billion in fully diluted shares outstanding, the overvaluation ranges between 10% and 74%.\n\nSource: Author's calculations.",
"sentiment": 0.8111,
"highlighted_in": "main_text"
},
{
"highlight": "This time I do not feel comfortable about the fair price even though I consider <em>Apple</em> to be great. The stock can be considered overvalued currently.",
"sentiment": 0.6933,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em>: A Compounding Machine Slowing Down",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "176a2820-3aba-45f3-9098-4145306ff481",
"title": "Apple Stock Is About to Get Dangerously Close to Its 52-Week Low (and It Doesn't Even Have to Go Down)",
"description": "Apple stock is under pressure with no end in sight.",
"keywords": "",
"snippet": "Investors in Apple (AAPL 2.12%) are not having a good 2024. The stock is down over 10% year to date, while the S&P 500 and Nasdaq Composite are up over 9%.\n\nIt'...",
"url": "https://www.fool.com/investing/2024/03/28/apple-stock-dangerously-close-52-week-low-buy/",
"image_url": "https://g.foolcdn.com/editorial/images/770420/getty-debt-worry-worried-concern-1200x732-81eb63d.jpg",
"language": "en",
"published_at": "2024-03-28T08:05:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 16.685978,
"sentiment_score": -0.078364,
"highlights": [
{
"highlight": "Investors in <em>Apple</em> (AAPL 2.12%) are not having a good 2024. The stock is down over 10% year to date, while the S&P 500 and Nasdaq Composite are up over 9%.\n\nIt's difficult for such a heavily weighted stock to underperform the broader benchmarks by that much in a short time.",
"sentiment": -0.469,
"highlighted_in": "main_text"
},
{
"highlight": "But <em>Apple</em> is dealing with several very real challenges and has largely missed out on the tech rally that is being fueled by artificial intelligence (AI).\n\nAs of March 22, <em>Apple</em> is now just 10.5% away from its 52-week low during a time when many other tech stocks are setting new all-time highs.",
"sentiment": 0.0972,
"highlighted_in": "main_text"
},
{
"highlight": "Here's why <em>Apple</em> is about to get even closer to its 52-week low even if the stock stays where it is, and whether you should buy it now.\n\n<em>Apple</em> stock is lapping lows\n\nApple's current 52-week low of $155.98 was reached on March 28, 2023. As the calendar rolls on, Apple's new 52-week low will get higher even if the stock price doesn't move.",
"sentiment": -0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "After May 4 (and assuming <em>Apple</em> doesn't go below this point), the new 52-week low will be $165.67 from Oct. 26, which is less than 5% below where <em>Apple</em> currently trades. By comparison, the stock's 52-week high of $199.62 occurred more recently, on Dec. 14, and it nearly exceeded that high just a couple of months ago in late January.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> is already closer to its recent low than its high, but it will get much closer to the low with time.\n\nOn a favorable note, it's worth mentioning how steady <em>Apple</em> has been. There is only a 20% swing from its 52-week high and the late-October low, meaning it has not been a volatile stock.",
"sentiment": 0.1655,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> is in a bit of a funk\n\nAs consistent as <em>Apple</em> has been, there are concerns that the investment thesis is weakening, setting the stage for further selling pressure. The company has a high success rate when it comes to hardware and accessories. But its current product pipeline is the most uncertain it has been in over a decade.",
"sentiment": -0.3102,
"highlighted_in": "main_text"
},
{
"highlight": "That all could change in a heartbeat if the Vison Pro becomes a resounding success, <em>Apple</em> launches an AI-enabled iPhone that is welcomed by users, or a lot of folks who bought new products during the height of the pandemic decide to upgrade.",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "But those results won't fully materialize until <em>Apple</em> reports its 2025 full-fiscal-year results in February 2026 -- a long time to wait.\n\nSingle-digit EPS growth is a negative outlook for <em>Apple</em>, especially because a few percentage points are due to buybacks.",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "With challenges compounding, I expect <em>Apple</em> to break to a new 52-week low, especially once the margin narrows between its current price and the new higher one-year low after March 28. But the more <em>Apple</em> falls, the better value it will become for long-term investors.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "The stock is worth buying now, but investors should closely monitor the performance of the Vision Pro and watch for updates at its Worldwide Developers Conference (usually early June) and its annual <em>Apple</em> Event (usually early to mid-September).",
"sentiment": 0.4497,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> Stock Is About to Get Dangerously Close to Its 52-Week Low (and It Doesn't Even Have to Go Down)",
"sentiment": -0.6249,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 6.579995,
"sentiment_score": -0.0265,
"highlights": [
{
"highlight": "This year, the best-performing stock in the Dow Jones Industrial Average isn't Salesforce or Amazon or <em>Microsoft</em> -- it's Walt Disney, which had underperformed the market for multiple years but is up 28% in less than three months.",
"sentiment": -0.0265,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^DJI",
"name": "Dow Jones Industrial Average",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 23.09782,
"sentiment_score": -0.0265,
"highlights": [
{
"highlight": "This year, the best-performing stock in the <em>Dow</em> <em>Jones</em> <em>Industrial</em> <em>Average</em> isn't Salesforce or Amazon or Microsoft -- it's Walt Disney, which had underperformed the market for multiple years but is up 28% in less than three months.",
"sentiment": -0.0265,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 13.807865,
"sentiment_score": -0.3612,
"highlights": [
{
"highlight": "The stock is down over 10% year to date, while the <em>S</em>&<em>P</em> <em>500</em> and Nasdaq Composite are up over 9%.\n\nIt's difficult for such a heavily weighted stock to underperform the broader benchmarks by that much in a short time.",
"sentiment": -0.3612,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MSFT.MI",
"name": "MICROSOFT CORP",
"exchange": null,
"exchange_long": null,
"country": "it",
"type": "equity",
"industry": "Technology",
"match_score": 6.571237,
"sentiment_score": -0.0265,
"highlights": [
{
"highlight": "This year, the best-performing stock in the Dow Jones Industrial Average isn't Salesforce or Amazon or <em>Microsoft</em> -- it's Walt Disney, which had underperformed the market for multiple years but is up 28% in less than three months.",
"sentiment": -0.0265,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "f571673a-ca94-460a-8edb-b20b90361114",
"title": "Amazon планирует потратить почти $150 млрд на ЦОД в ближайшие 15 лет",
"description": "Увеличение расходов — это демонстрация силы, поскольку компания стремится сохранить преимущество облачных вычислений над Microsoft и Google",
"keywords": "Amazon, ЦОД",
"snippet": "Ставка Amazon.com Inc. на центры обработки данных даст гиганту облачных вычислений мощь, позв?...",
"url": "https://inventure.com.ua/news/world/amazon-planiruet-potratit-pochti-dollar150-mlrd-na-cod-v-blizhajshie-15-let",
"image_url": "https://inventure.com.ua/upload/pic2024-1H/19340bc7508b3f5230a8ec8a0fc0d802.jpg",
"language": "ru",
"published_at": "2024-03-28T13:43:07.000000Z",
"source": "inventure.com.ua",
"relevance_score": null,
"entities": [
{
"symbol": "AMZN",
"name": "Amazon.com, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.602976,
"sentiment_score": null,
"highlights": [
{
"highlight": "Ставка <em>Amazon.com</em> <em>Inc</em>. на центры обработки данных даст гиганту облачных вычислений мощь, позволяющую справиться с ожидаемым взрывным ростом спроса на приложения искусственного интеллекта и другие цифровые услуги.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "ea2c6427-6b8e-44d7-84ab-e38ba34f4ca5",
"title": "NanoVibronix signs agreement with Veranex (NASDAQ:NAOV)",
"description": "NanoVibronix signs agreement with Veranex for research and development of next-gen PainShield and UroShield products.",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/news/4084940-nanovibronix-signs-agreement-with-veranex",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-03-28T13:39:40.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "NAOV",
"name": "NanoVibronix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 110.04528,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "<em>NanoVibronix</em> signs agreement with Veranex (<em>NASDAQ:NAOV</em>)",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "b2742703-8468-4b90-8a6f-77513f8258d7",
"title": "T2 Biosystems extends contract with Vizient (NASDAQ:TTOO)",
"description": "T2 Biosystems extends supplier agreement with Vizient until 2025, covering sepsis-detecting products; a significant development in the healthcare industry.",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/news/4084939-t2-biosystems-extends-contract-with-vizient",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-03-28T13:36:30.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "TTOO",
"name": "T2 Biosystems, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 129.57806,
"sentiment_score": 0.128,
"highlights": [
{
"highlight": "<em>T2</em> <em>Biosystems</em> extends contract with Vizient (<em>NASDAQ:TTOO</em>)",
"sentiment": 0.128,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "85ccc9cd-2d43-4260-93da-2382ea971da8",
"title": "Maxlinear, ON Semiconductor, Diodes among Benchmark's favored tech supply chain stocks",
"description": "Maxlinear (MXL), ON Semiconductor (ON) and Diodes (DIOD) are among the tech supply chain stocks favored by Benchmark. Read for more.",
"keywords": "",
"snippet": "Maxlinear (NASDAQ:MXL), ON Semiconductor (NASDAQ:ON) and Diodes (NASDAQ:DIOD) are among the tech supply chain stocks favored by Benchmark, as the research firm ...",
"url": "https://seekingalpha.com/news/4084935-maxlinear-on-semiconductor-diodes-among-benchmarks-favored-tech-supply-chain-stocks",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/478915324/image_478915324.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2024-03-28T13:35:07.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ON",
"name": "ON Semiconductor Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 53.480812,
"sentiment_score": 0.520367,
"highlights": [
{
"highlight": "Maxlinear (NASDAQ:MXL), <em>ON</em> <em>Semiconductor</em> (<em>NASDAQ:ON</em>) and Diodes (NASDAQ:DIOD) are among the tech supply chain stocks favored by Benchmark, as the research firm the supply chain moving toward \"normalization\" and strong demand in the second-half of the year.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, the automotive and industrial markets look to be nearing a bottom, which should benefit <em>ON</em> <em>Semiconductor</em>, Diodes and Indie, Williams said.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Maxlinear, <em>ON</em> <em>Semiconductor</em>, Diodes among Benchmark's favored tech supply chain stocks",
"sentiment": 0.4215,
"highlighted_in": "title"
}
]
},
{
"symbol": "LSCC",
"name": "Lattice Semiconductor Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 33.872086,
"sentiment_score": 0.8519,
"highlights": [
{
"highlight": "Also favored by Benchmark are <em>Lattice</em> <em>Semiconductor</em> (<em>NASDAQ:LSCC</em>), indie Semiconductor (INDI), and Ideal Power (IPWR).\n\nMaxLinear is seen as a \"bit of a contrarian call,\" given that shares are 50% below their 52-week high and the company is dealing with its fifth straight consecutive decline in quarterly sales.",
"sentiment": 0.8519,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b3422dce-8c8c-44d9-91ae-7918a550da04",
"title": "Quick Thoughts: Do Elections Matter For Markets?",
"description": "The upcoming US elections transcend political rivalry. Franklin Institute's Stephen Dover examines policy differences between the major parties and their potential implications on markets.",
"keywords": "",
"snippet": "gguy44\n\nBy Stephen H. Dover, CFA, Chief Market Strategist, Head of Franklin Templeton Institute\n\nThe upcoming US presidential elections transcend mere political...",
"url": "https://seekingalpha.com/article/4680969-quick-thoughts-do-elections-matter-for-markets",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491230368/image_1491230368.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-28T13:35:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 7.363759,
"sentiment_score": 0.5945,
"highlights": [
{
"highlight": "At the same time, many large-cap equities outside the “Magnificent Seven” (<em>Alphabet</em> (GOOG, <em>GOOGL</em>), Amazon (AMZN), Apple (AAPL), Meta (META), Microsoft (MSFT), Nvidia (NVDA) and Tesla (TSLA)) are showing earnings expectations that exceed market averages at what we consider to be more attractive valuations.",
"sentiment": 0.5945,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "4a76e94f-31d4-4ecc-a48e-f951ef0bfd40",
"title": "Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering",
"description": "CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical...",
"keywords": "Nasdaq:TNXP, Tonix Pharmaceuticals Holding Corp.",
"snippet": "CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical com...",
"url": "https://www.globenewswire.com/news-release/2024/03/28/2854099/28908/en/Tonix-Pharmaceuticals-Announces-Pricing-of-4-4-Million-Registered-Direct-Offering.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/16aad249-3d33-4501-b3d9-118a703fa46e",
"language": "en",
"published_at": "2024-03-28T13:32:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "TNXP",
"name": "Tonix Pharmaceuticals Holding Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.687836,
"sentiment_score": 0.4232,
"highlights": [
{
"highlight": "., March 28, 2024 (GLOBE NEWSWIRE) -- <em>Tonix</em> <em>Pharmaceuticals</em> <em>Holding</em> <em>Corp</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>TNXP</em>) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a securities purchase agreement with existing healthcare focused institutional investors of the Company for the purchase and sale of 14,666,666 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tonix</em> <em>Pharmaceuticals</em> <em>Holding</em> <em>Corp</em>.*\n\nTonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (CNS) disorders.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "7baa8068-781d-4e99-a5c6-460ba84bf464",
"title": "Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day",
"description": "CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (",
"keywords": "Nasdaq:CPRX, Catalyst Pharmaceuticals, Inc., AGAMREE, Firdapse, Fycompa, Lems, Lambert Eaton, Rare disease, Ruzurgi, Myasthenia, gravis, muscular dystrophy, awareness, neuromuscular, DMD",
"snippet": "CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (\"Catalyst\") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharma...",
"url": "https://www.globenewswire.com/news-release/2024/03/28/2853962/13009/en/Catalyst-Pharmaceuticals-Announces-Support-for-the-Inaugural-Lambert-Eaton-Myasthenic-Syndrome-LEMS-Awareness-Day.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/960a6989-9f9c-4ad2-91cf-be10cebd6655",
"language": "en",
"published_at": "2024-03-28T12:03:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CPRX",
"name": "Catalyst Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 92.89751,
"sentiment_score": 0.331933,
"highlights": [
{
"highlight": "., March 28, 2024 (GLOBE NEWSWIRE) -- <em>Catalyst</em> <em>Pharmaceuticals</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(\"Catalyst\") (<em>Nasdaq</em>: <em>CPRX</em>), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult-to-treat diseases, today announced its endorsement of the inaugural Lambert-Eaton myasthenic syndrome (\"LEMS\") Awareness Day.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Catalyst</em> <em>Pharmaceuticals</em>, <em>Inc</em>.\n\nWith exceptional patient focus, Catalyst is committed to developing and commercializing innovative first-in-class medicines that address rare and difficult-to-treat diseases.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about <em>Catalyst</em> <em>Pharmaceuticals</em>, <em>Inc</em>., visit the Company's website at www.catalystpharma.com. For Full Prescribing and Safety Information for FIRDAPSE®, visit www.firdapse.com. For Full Prescribing Information, including Boxed WARNING for FYCOMPA®, please visit www.fycompa.com.",
"sentiment": 0.2422,
"highlighted_in": "main_text"
},
{
"highlight": "Source: <em>Catalyst</em> <em>Pharmaceuticals</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Catalyst</em> <em>Pharmaceuticals</em> Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "723eadc3-45ce-4211-8342-6b53d82c4bd2",
"title": "Tesla-Aktie mit Verlusten: Scholz ist pro Tesla-Ausbau",
"description": "Bundeskanzler Olaf Scholz (SPD) unterstützt den geplanten Ausbau des einzigen europäischen Werks von US-Elektroautobauer Tesla in Grünheide bei Berlin. 28.03.2024",
"keywords": "",
"snippet": "Unterstützung\n\nBundeskanzler Olaf Scholz (SPD) unterstützt den geplanten Ausbau des einzigen europäischen Werks von US-Elektroautobauer Tesla in Grünheide b...",
"url": "https://www.finanzen.net/nachricht/aktien/unterstuetzung-kanzler-scholz-befuerwortet-tesla-ausbau-in-gruenheide-13378852",
"image_url": "https://images.finanzen.net/mediacenter/unsortiert/tesla-nadezda-murmakova-660-0690.jpg",
"language": "de",
"published_at": "2024-03-28T13:32:00.000000Z",
"source": "finanzen.net",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 34.74254,
"sentiment_score": null,
"highlights": [
{
"highlight": "Unterstützung\n\nBundeskanzler Olaf Scholz (SPD) unterstützt den geplanten Ausbau des einzigen europäischen Werks von US-Elektroautobauer <em>Tesla</em> in Grünheide bei Berlin.",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em> will die geplante Produktion von 500 000 Autos im Jahr verdoppeln, derzeit sind es hochgerechnet rund 300 000 Autos. Umweltschützer und Anwohner haben große Bedenken dagegen, weil das Werk teils im Wasserschutzgebiet liegt.",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "Der Kanzler verurteilte den Anschlag auf die Stromversorgung von <em>Tesla</em> und dringt auf Aufklärung. \"Das war ein terroristischer Akt\", sagte Scholz. \"Polizei und Sicherheitsbehörden müssen alles tun, um die Täter zu identifizieren und ihrer gerechten Strafe zuzuführen.\"",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "Bisher unbekannte Täter hatten Anfang März Feuer an einem Strommast gelegt, der Teil der Stromversorgung des <em>Tesla</em>-Werks ist. Wegen eines Stromausfalls lag die Autoproduktion fast eine Woche lang auf Eis. Die linksextreme \"Vulkangruppe\" erklärte, sie sei für den Anschlag verantwortlich. Der Generalbundesanwalt ermittelt.",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "Im NASDAQ-Handel verliert die <em>Tesla</em>-Aktie zeitweise 1,36 Prozent auf 177,39 US-Dollar. GRÜNHEIDE/KÖLN (dpa-AFX)",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em>-Aktie mit Verlusten: Scholz ist pro <em>Tesla</em>-Ausbau",
"sentiment": null,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 1464,
"sentiment_avg": 0.2873874803016518
}
]
}
Other details
Country
- us
- 5,275